low
risk
topic
retinoid
mechlorethamin
gel
ointment
topic
steroid
without
occlus
imiquimod
home
narrowband
uvb
phototherapi
nbuvb
heliotherapi
oral
antibiot
oral
antiprurit
dilut
vinegar
bleach
soaksbath
aggress
moistur
b
intermedi
risk
oral
retinoid
bexaroten
acitretin
isotretinoin
methotrex
oral
steroid
vorinostat
interferon
alpha
gamma
c
high
risk
pralatrex
romidepsin
mogamulizumab
brentuximab
gemcitabin
chemotherapi
skin
radiotherapi
photopheresi
officebas
uv
therapi
high
risk
due
travel
lowrisk
therapi
util
home
continu
patient
risk
travel
exposur
like
outweigh
benefit
inoffic
treatment
ultraviolet
light
therapi
total
bodi
electron
beam
radiat
therapi
homebas
nbuvb
heliotherapi
continu
initi
patient
lowrisk
diseas
lowrisk
therapi
recommend
intermediaterisk
therapi
may
continu
dose
adjust
may
advis
individu
basi
least
frequent
lab
monitor
possibl
perform
limit
exposur
ensur
patient
safeti
initi
therapi
may
postpon
use
lowrisk
bridg
therapi
short
term
increas
initi
retinoid
interferon
consid
case
necessit
remov
highrisk
therapi
highrisk
therapi
addit
inher
risk
may
requir
travel
clinic
hospit
util
highest
risk
patient
addit
risk
therapyrel
travel
consid
infus
regimen
may
adjust
increas
treatment
interv
romidepsin
mogamulizumab
may
consid
individu
basi
extend
interv
lower
dose
allogen
stem
cell
transplant
treatment
chop
alemtuzumab
fludarabin
strongli
discourag
pandem
often
lead
signific
cytopenia
known
risk
factor
complic
consid
altern
lower
risk
therapi
whenev
possibl
